Canada Markets closed

Nuvo Pharmaceuticals Inc. (MRVFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.5800+0.0200 (+3.57%)
At close: 01:06PM EDT
Full screen
Loading interactive chart...
  • Business Wire

    Miravo Healthcare™ Announces Appointment of Anthony Snow to its Board of Directors

    MISSISSAUGA, Ontario, August 16, 2022--Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced the appointment of Anthony Snow to its Board of Directors (Board) on August 12, 2022.

  • Business Wire

    Miravo Healthcare™ Announces Second Quarter 2022 Results

    MISSISSAUGA, Ontario, August 15, 2022--Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced its financial and operational results for the three and six months ended June 30, 2022. For further details on the results, please refer to Miravo’s Management, Discussion and Analysis (MD&A) and Condensed Consolidated Interim Financial St

  • Business Wire

    Miravo Healthcare™ Announces Second Quarter 2022 Results Release Date and Conference Call Details

    MISSISSAUGA, Ontario, August 02, 2022--Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today announced it expects to release its second quarter 2022 financial results before markets open on Monday, August 15, 2022.